Pheal

Mumbai, India Founded: 2021 • Age: 5 yrs Minicorn
A digitized prescription tool is provided for physical therapists.

About Pheal

Pheal is a Healthcare company based in Mumbai (India) founded in 2021 by Surya Agarwal. A digitized prescription tool is provided for physical therapists. Pheal has raised $284.52 thousand across 1 funding round from investors including Maheshwari Investors Private Limited, Pratik Agarwal and Surya Agarwal. The company has 1 employees. Pheal was last valued at $1.59 million in August 2022. Its Indian entity Pompey Health Tech Private Limited reported revenue of β‚Ή7.2 Lakh. Its focus areas include HealthTech, Healthcare IT, Provider and Aids for Doctors. Its competitors include WonDRx and SimboAlpha; 2 of its 2 listed competitors have raised funding.

Company details

Pheal was founded in 2021 in Mumbai, India, as a provider in the healthcare technology sector. A digital platform is offered to physical therapists, enabling prescription generation, patient personalization, user-generated content creation, and ongoing monitoring. Adherence to therapy plans is supported through these features. Operations center on streamlining physiotherapy workflows in the Indian market.

  • Headquarters Mumbai, India
  • Employees 1
  • Founders Surya Agarwal
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pheal.in
  • Social LinkedIn Facebook
  • Legal Name Pompey Health Tech Private Limited
  • Date of Incorporation 09 Dec, 2021
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹7.2 Lakh

    FY 2024 · +176% YoY

  • Net Loss
    -₹71.5 Lakh

    FY 2024 · -988% margin

  • EBITDA
    -₹51.4 Lakh

    FY 2024 · -710% margin

  • Total Equity Funding
    $284.52K (USD)

    in 1 rounds

  • Latest Funding Round
    $284.52K (USD), Seed

    Aug 2022

  • Investors
  • Employee Count
    1

Funding Insights of Pheal

Pheal has successfully raised a total of $284.52K through 1 strategic funding round. The most recent funding activity was a Seed round of $284.52 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $284,522
  • Total Rounds 1
  • Last Round Seed β€” $284,522
  • First Round $284,522

    (Aug 2022)

  • Investors Count 3

All 1 funding rounds of Pheal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2022$284,522Seed$1.59MMIPL
Valuation history
DateValuationStage
Aug 2022$1.59Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.59M (Aug 2022). 3 investors in total: 1 institutional and 2 angel.

Investors in Pheal

Pheal has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Maheshwari Investors Private Limited, Pratik Agarwal and Surya Agarwal.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Investment services are provided by Maheshwari Investors Private Limited.
mipl.orgMumbai, India

Pratik Agarwal

Angel investor and entrepreneur, focused on tech startups, based in India.
unknown_89e635d9af3545348

Surya Agarwal

Angel investor and entrepreneur, co-founder of TribeVibe, focused on entertainment tech.
unknown_1bbb0d3217964d34a
Premium access

Investor details for Pheal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Pompey Health Tech Private Limited (Pheal)

Pompey Health Tech Private Limited is the primary company behind Pheal. The board of Pompey Health Tech Private Limited currently have 2 directors; the longest-serving is Surya Ajay Agarwal, appointed in 2021. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Surya Ajay Agarwal
DIN 09429966
Director09 Dec 20214 yrs 11 moPompey Health Tech Private Limited
Neena Ajay Agarwal
DIN 00454717
Director29 Nov 20232 yrs 11 moPompey Health Tech Private Limited

People of Pheal

1 people are tracked at Pheal (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Co-FounderLeadership
Premium access

Complete people profiles for Pheal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Pheal

Figures of Pompey Health Tech Private Limited, the primary company behind Pheal, for FY 2024. Revenue was ₹7.2 Lakh (+176% year on year). Net loss was -₹71.5 Lakh (-988% margin). EBITDA was -₹51.4 Lakh (-710% margin).

  • ₹7.2 LakhRevenue · FY 2024 · +176% YoY
  • -₹71.5 LakhNet loss · -988% margin
  • -₹51.4 LakhEBITDA · -710% margin
  • ₹1.2 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Pompey Health Tech Private Limited are on its company page.

Premium access

Detailed financial statements for Pheal

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Pheal

3 dated milestones of Pheal across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pheal is founded.
  2. Funding First funding round of $285K.
  3. Milestone Reaches Minicorn status.

Competitors of Pheal

Pheal has 2 listed competitors in our database, 2 of them funded. They include WonDRx and SimboAlpha.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
wondrx.com2017Mumbai, India$3.24M12
EHR facilitator solutions are provided for healthcare professionals' record management.
simboalpha.com2013Bengaluru, India$880,691
AI-based EMR management is offered to healthcare professionals.
Premium access

Detailed competitors of Pheal

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pheal

Pheal was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Pheal is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Pheal is a funded company, having raised a total of $284.52K across 1 funding round to date. The company's 1st funding round was a Seed of $284.52K, raised on Aug 2022.

Pheal has 1 employees.

The primary company behind Pheal, Pompey Health Tech Private Limited, reported revenue of β‚Ή7.2 Lakh for FY 2024, up 176% year on year.

Pheal was founded in 2021 in Mumbai, India, as a provider in the healthcare technology sector. A digital platform is offered to physical therapists, enabling prescription generation, patient personalization, user-generated content creation, and ongoing monitoring. Adherence to therapy plans is supported through these features. Operations center on streamlining physiotherapy workflows in the Indian market.

Pheal's top competitors include SimboAlpha and WonDRx.

Pheal has 3 investors. Key investors include Maheshwari Investors Private Limited, Pratik Agarwal, and Surya Agarwal.

The valuation of Pheal is $1.59M as of Aug 2022.

Pheal operates through Pompey Health Tech Private Limited.

The legal entities of Pheal currently have 2 directors, including Neena Ajay Agarwal, Surya Ajay Agarwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available